文献速递胰腺与胆道疾病消化内镜

预测术后胆漏内镜治疗后是否需要重复ERCP的临床预测规则

Clinical prediction rule to determine the need for repeat ERCP after endoscopic treatment of postsurgical bile leaks.
PubMed 文献 · Gastrointest Endosc · 2016-10-31

基于2000至2012年259例因手术所致胆漏接受ERCP的患者,采用多因素分析和二元递归划分分析建立预测重复内镜评估无胆道病变的规则。规则含腹腔镜胆囊切除术、术后碱性磷酸酶正常、初次ERCP示少量漏且无其他病变、初次至重复ERCP间隔4至8周四项标准,全部满足时灵敏度94%(95%CI 83%-99%)、阴性预测值93%(95%CI 81%-99%)。作者认为该规则可识别经胃镜拔除胆道支架的患者。

要点

  • 术后碱性磷酸酶正常与重复ERCP无胆道病变独立相关(OR 2.26,95%CI 1.03-4.99)。
  • 手术至首次ERCP间隔小于8天与无持续胆漏独立相关(OR 2.47,95%CI 1.15-5.31)。
  • 初次ERCP示少量漏且无其他病变与无持续胆漏独立相关(OR 6.74,95%CI 1.75-25.89)。

核心结论

  • 该临床决策规则可识别可通过胃镜拔除胆道支架的患者,可能改善患者安全与医疗资源利用。

研究设计与样本

  • 2000至2012年基于人群的研究,纳入所有因手术所致胆漏接受ERCP的患者,共259例。
  • 采用多因素分析和二元递归划分分析生成预测重复内镜评估无胆道病变的规则。

主要发现

  • 多因素分析显示术后碱性磷酸酶正常(OR 2.26,95%CI 1.03-4.99)与重复ERCP无持续胆漏及其他病变独立相关。
  • 手术至首次ERCP间隔小于8天(OR 2.47,95%CI 1.15-5.31)与重复ERCP无持续胆漏及其他病变独立相关。
  • 初次ERCP示少量漏且无其他病变(OR 6.74,95%CI 1.75-25.89)与重复ERCP无持续胆漏及其他病变独立相关。
  • 规则含腹腔镜胆囊切除术、术后碱性磷酸酶正常、初次ERCP示少量漏且无其他病变、初次至重复ERCP间隔4至8周四项标准。
  • 全部4项标准满足时,规则灵敏度94%(95%CI 83%-99%),阴性预测值93%(95%CI 81%-99%);乐观度校正后灵敏度88%(95%CI 76%-96%),阴性预测值86%(95%CI 73%-96%)。

关键数值与推荐

  • 规则标准:腹腔镜胆囊切除术、术后碱性磷酸酶正常、初次ERCP示少量漏且无其他病变、初次至重复ERCP间隔4至8周。
  • 全部4项标准满足时灵敏度94%(95%CI 83%-99%),阴性预测值93%(95%CI 81%-99%)。
  • 乐观度校正后灵敏度88%(95%CI 76%-96%),阴性预测值86%(95%CI 73%-96%)。

临床怎么用

  • 作者认为该临床决策规则可识别可通过胃镜拔除胆道支架的患者。
  • 作者认为该规则可能改善患者安全与医疗资源利用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In patients who have undergone ERCP with biliary stenting for postsurgical bile leaks, the optimal method (ERCP or gastroscopy) and timing of stent removal is controversial. We developed a clinical prediction rule to identify cases in which a repeat ERCP is unnecessary. METHODS: Population-based study of all patients who underwent ERCP for management of surgically induced bile leaks between 2000 and 2012. Multivariate and binary recursive partitioning analyses were performed to generate a rule predicting the absence of biliary pathology on repeat endoscopic evaluation. RESULTS: A total of 259 patients were included. On multivariate analysis, postsurgical normal alkaline phosphatase (ALP; OR, 2.26; 95% CI, 1.03-4.99), time from surgery to first ERCP < 8 days (OR, 2.47; 95% CI, 1.15-5.31), and minor leak with no other pathology on initial ERCP (OR, 6.74; 95% CI, 1.75-25.89) were independently associated with the absence of persistent bile leak and other pathology on repeat ERCP. The derived rule included laparoscopic cholecystectomy, normal postsurgical ALP, minor leak with no other pathology on initial ERCP, and an interval from initial to repeat ERCP between 4 and 8 weeks. When all 4 criteria were met, the rule had a sensitivity of 94% (95% CI, 83%-99%) and a negative predictive value of 93% (95% CI, 81%-99%). Optimism-adjusted sensitivity and negative predictive value were 88% (95% CI, 76%-96%) and 86% (95% CI, 73%-96%), respectively. CONCLUSIONS: This clinical decision rule identifies patients who can have their biliary stents removed via gastroscopy, which may improve patient safety and healthcare utilization.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Tsolakis AV, James PD, Kaplan GG, et al. Clinical prediction rule to determine the need for repeat ERCP after endoscopic treatment of postsurgical bile leaks. Gastrointest Endosc. 2016. PMID: 27810250. doi:10.1016/j.gie.2016.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。